亚洲免费av电影一区二区三区,日韩爱爱视频,51精品视频一区二区三区,91视频爱爱,日韩欧美在线播放视频,中文字幕少妇AV,亚洲电影中文字幕,久久久久亚洲av成人网址,久久综合视频网站,国产在线不卡免费播放

        ?

        Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

        2021-01-07 23:21:09EdwardWalshetal
        四川生理科學(xué)雜志 2021年1期

        Edward E Walsh, et al.

        Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and the resulting disease,coronavirus disease 2019 (Covid-19), have spread to millions of persons worldwide.Multiple vaccine candidates are under development, but no vaccine is currently available.Interim safety and immunogenicity data about the vaccine candidate BNT162b1 in younger adults have been reported previously from trials in Germany and the United States.

        Methods: In an ongoing, placebo-controlled, observer-blinded, dose-escalation, phase 1 trial conducted in the United States,we randomly assigned healthy adults 18 to 55 years of age and those 65 to 85 years of age to receive either placebo or one of two lipid nanoparticle-formulated, nucleoside-modified RNA vaccine candidates: BNT162b1, which encodes a secreted trimerized SARS-CoV-2 receptor-binding domain; or BNT162b2, which encodes a membrane-anchored SARS-CoV-2 full-length spike, stabilized in the prefusion conformation.The primary outcome was safety (e.g., local and systemic reactions and adverse events); immunogenicity was a secondary outcome.Trial groups were defined according to vaccine candidate, age of the participants, and vaccine dose level (10 μg, 20 μg, 30 μg, and 100 μg).In all groups but one, participants received two doses, with a 21-day interval between doses; in one group (100 μg of BNT162b1), participants received one dose.

        Results: A total of 195 participants underwent randomization.In each of 13 groups of 15 participants, 12 participants received vaccine and 3 received placebo.BNT162b2 was associated with a lower incidence and severity of systemic reactions than BNT162b1, particularly in older adults.In both younger and older adults, the two vaccine candidates elicited similar dose-dependent SARS-CoV-2-neutralizing geometric mean titers, which were similar to or higher than the geometric mean titer of a panel of SARS-CoV-2 convalescent serum samples.

        Conclusions: The safety and immunogenicity data from this U.S.phase 1 trial of two vaccine candidates in younger and older adults, added to earlier interim safety and immunogenicity data regarding BNT162b1 in younger adults from trials in Germany and the United States, support the selection of BNT162b2 for advancement to a pivotal phase 2-3 safety and efficacy evaluation.(Funded by BioNTech and Pfizer; ClinicalTrials.gov number, NCT04368728.).

        日韩av水蜜桃一区二区三区| 国产夫妻av| 久久无码中文字幕东京热| 久久国产精品免费专区| 男人扒开女人双腿猛进视频| 丰满人妻被中出中文字幕| 亚洲中文字幕巨乳人妻| 亚洲av高清一区二区| 国产精品白丝久久av网站| 国产女女精品视频久热视频| 亚洲精品自拍视频在线观看| 亚洲综合一区二区三区在线观看| 精品乱人伦一区二区三区| 开心婷婷五月激情综合社区| 中文字幕大乳少妇| 日本加勒比精品一区二区视频| 午夜理论片yy6080私人影院| 欧美人与物videos另类xxxxx| 蜜桃av夺取一区二区三区| 久久精品日本不卡91| 激情第一区仑乱| 99久久综合九九亚洲| 中文字幕日本在线乱码| 国产v片在线播放免费无码| 精品人妻无码一区二区色欲产成人| 无码丰满熟妇浪潮一区二区av| 精品一级一片内射播放| 日本黄网站三级三级三级| 无码AV高潮喷水无码专区线| 精品女同一区二区三区亚洲| 无码日韩精品一区二区免费暖暖| 色综合中文综合网| 久久精品韩国日本国产| 亚洲丝袜美腿在线视频| 亚洲精品国偷拍自产在线麻豆| 精品国产亚欧无码久久久| 男女深夜视频网站入口| 亚洲妇女自偷自偷图片| 美女裸体无遮挡免费视频的网站| 亚洲一区二区三区在线激情| 人妻在卧室被老板疯狂进入|